Andrea L. Hazen, John R. Walker, Gloria D. Eldridge
{"title":"Anxiety sensitivity and treatment outcome in panic disorder","authors":"Andrea L. Hazen, John R. Walker, Gloria D. Eldridge","doi":"10.1002/(SICI)1522-7154(1996)2:1<34::AID-ANXI5>3.0.CO;2-D","DOIUrl":null,"url":null,"abstract":"<p>The purpose of this study was to examine the relationship between change in anxiety sensitivity, as measured by the Anxiety Sensitivity Index (ASI), and treatment outcome in a sample of 106 subjects with a DSM-III-R diagnosis of panic disorder (with or without agoraphobia) who were participants in an evaluation study of cognitive-behavioral treatment. Results revealed that subjects who received active treatment had significantly lower anxiety sensitivity scores at post-treatment than the wait-list control group. We also examined change in anxiety sensitivity from pre- to post-treatment in reference to Clinical Global Improvement (CGI) ratings and with the effect size statistic. Subjects who showed improvement based on CGI ratings also demonstrated a reduction in anxiety sensitivity. Furthermore, the effect sizes obtained with the ASI were greater in magnitude than those obtained with other widely used anxiety self-report measures. Taken together, the finds supported the use of the Anxiety Sensitivity Index as a treatment outcome measure in panic disorder research. Anxiety 2:34–39 (1996). © 1996 Wiley-Liss, Inc.</p>","PeriodicalId":79474,"journal":{"name":"Anxiety","volume":"2 1","pages":"34-39"},"PeriodicalIF":0.0000,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/(SICI)1522-7154(1996)2:1<34::AID-ANXI5>3.0.CO;2-D","citationCount":"32","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anxiety","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/%28SICI%291522-7154%281996%292%3A1%3C34%3A%3AAID-ANXI5%3E3.0.CO%3B2-D","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 32
Abstract
The purpose of this study was to examine the relationship between change in anxiety sensitivity, as measured by the Anxiety Sensitivity Index (ASI), and treatment outcome in a sample of 106 subjects with a DSM-III-R diagnosis of panic disorder (with or without agoraphobia) who were participants in an evaluation study of cognitive-behavioral treatment. Results revealed that subjects who received active treatment had significantly lower anxiety sensitivity scores at post-treatment than the wait-list control group. We also examined change in anxiety sensitivity from pre- to post-treatment in reference to Clinical Global Improvement (CGI) ratings and with the effect size statistic. Subjects who showed improvement based on CGI ratings also demonstrated a reduction in anxiety sensitivity. Furthermore, the effect sizes obtained with the ASI were greater in magnitude than those obtained with other widely used anxiety self-report measures. Taken together, the finds supported the use of the Anxiety Sensitivity Index as a treatment outcome measure in panic disorder research. Anxiety 2:34–39 (1996). © 1996 Wiley-Liss, Inc.
惊恐障碍患者的焦虑敏感性与治疗结果
本研究的目的是检验焦虑敏感性的变化(由焦虑敏感性指数(ASI)测量)与106名被诊断为DSM-III-R诊断为惊恐障碍(伴有或不伴有广场恐怖症)的受试者样本的治疗结果之间的关系,这些受试者是认知行为治疗评估研究的参与者。结果显示,接受积极治疗的受试者在治疗后的焦虑敏感性得分明显低于等候名单对照组。我们还根据临床总体改善(CGI)评分和效应量统计,检查了治疗前和治疗后焦虑敏感性的变化。在CGI评分基础上表现出改善的受试者也表现出焦虑敏感性的降低。此外,与其他广泛使用的焦虑自我报告测量方法相比,ASI获得的效应量更大。综上所述,这些发现支持在恐慌症研究中使用焦虑敏感性指数作为治疗结果的衡量标准。焦虑2:34-39(1996)。©1996 Wiley-Liss, Inc
本文章由计算机程序翻译,如有差异,请以英文原文为准。